<DOC>
	<DOCNO>NCT01613703</DOCNO>
	<brief_summary>The primary objective study evaluate brain TSPO occupancy ONO-2952 healthy adult subject single dose use [ 11C ] PBR28 specific PET ligand TSPO . The secondary objective evaluate relationship TSPO occupancy plasma concentration ONO-2952 investigate safety tolerability ONO-2952 healthy subject .</brief_summary>
	<brief_title>ONO-2952 Single-dose PET Study Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy nonsmoking male female subject ( 1855 inclusive ) Body mass index ( BMI ) 1935 kg/m2 ( inclusive ) For female , surgically sterilize , postmenopausal , non lactate agree use double barrier method contraception History presence clinically significant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>ONO-2952</keyword>
	<keyword>Healthy adult subject</keyword>
	<keyword>single doe</keyword>
	<keyword>PET study</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
</DOC>